Coordinated action of protein tyrosine phosphatases in insulin signal transduction

European Journal of Biochemistry

Volumn 269, Issue 4, 2002, Pages 1050-1059

  Cheng, Alan ^a   Dubé, Nadia ^a   Gu, Feng ^a   Tremblay, Michel L ^a  

^a MCGILL UNIVERSITY   (Canada)

Author keywords

Diabetes; Insulin receptor; Knockout mice; Protein tyrosine phosphatase; Signaling

Indexed keywords

INSULIN; INSULIN RECEPTOR; ISOPROTEIN; PROTEIN; PROTEIN LAR; PROTEIN SAP 1; PROTEIN TYROSINE PHOSPHATASE; PROTEIN TYROSINE PHOSPHATASE SHP 2; UNCLASSIFIED DRUG;

DIABETES MELLITUS; ENZYME ACTIVITY; ENZYME SPECIFICITY; GLUCOSE HOMEOSTASIS; INSULIN METABOLISM; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEPHOSPHORYLATION; RECEPTOR BINDING; SHORT SURVEY; SIGNAL TRANSDUCTION;

CELL COMPARTMENTATION; INSULIN; MULTIGENE FAMILY; PROTEIN-TYROSINE-PHOSPHATASE; RECEPTOR CROSS-TALK; RECEPTOR, INSULIN; SIGNAL TRANSDUCTION;

EID: 0036183603     PISSN: 00142956     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.0014-2956.2002.02756.x     Document Type: Short Survey

References (121)

1. Human type 1 diabetes and the insulin gene: Principles of mapping polygenes
2. Diagnosis and treatment of pre-insulin dependent diabetes
3. New perspectives into the molecular pathogenesis and treatment of type 2 diabetes
4. Cell signaling by receptor tyrosine kinases
5. The insulin signaling system
6. Functions of SH2 and SH3 domains
7. The IRS-signalling system: A network of docking proteins that mediate insulin action
8. Role of binding proteins to IRS-1 in insulin signalling
9. Insulin-induced phosphorylation of the 46- and 52-kDa Shc proteins
10. The SH2/SH3 domain-containing protein GRB2 interacts with tyrosine- phosphorylated IRS1 and Shc: Implications for insulin control of ras signalling
11. Molecular basis of insulin-stimulated GLUT4 vesicle trafficking. Location! Location! Location!
12. GLUT4 gene regulation and manipulation
13. Glucose transporters and insulin action - Implications for insulin resistance and diabetes mellitus
14. Insulin-stimulated GLUT4 translocation requires the CAP-dependent activation of TC10
15. CAP defines a second signalling pathway required for insulin-stimulated glucose transport
16. Combinatorial control of the specificity of protein tyrosine phosphatases
17. Multifunctional actions of vanadium compounds on insulin signaling pathways: Evidence for preferential enhancement of metabolic versus mitogenic effects
18. Peroxovanadium compounds: Biological actions and mechanism of insulin-mimesis
19. The chemistry of peroxovanadium compounds relevant to insulin mimesis
20. Glycosylation of nucleocytoplasmic proteins: Signal transduction and O-GlcNAc
21. Protein tyrosine phosphatases
22. Distinct functional roles of the two intracellular phosphatase like domains of the receptor-linked protein tyrosine phosphatases LCA and LAR
23. Purification and characterization of the catalytic domains of the human receptor-linked protein tyrosine phosphatases HPTP beta, leukocyte common antigen (LCA), and leukocyte common antigen-related molecule (LAR)
24. Molecular cloning and tissue-specific RNA processing of a murine receptor-type protein tyrosine phosphatase
25. Development of substrate-trapping mutants to identify physiological substrates of protein tyrosine phosphatases
26. Combination of gene targeting and substrate trapping to identify substrates of protein tyrosine phosphatases using PTP-PEST as a model
27. Identification of protein-tyrosine phosphatases prevalent in adipocytes by molecular cloning
28. Purification, identification and subcellular distribution of three predominant protein-tyrosine phosphatase enzymes in skeletal muscle tissue
29. Alterations in skeletal muscle protein-tyrosine phosphatase activity and expression in insulin-resistant human obesity and diabetes
30. Mutational analysis of proprotein processing, subunit association, and shedding of the LAR transmembrane protein tyrosine phosphatase
31. Cellular redistribution of protein tyrosine phosphatases LAR and PTPsigma by inducible proteolytic processing
32. Expression of the receptor-linked protein tyrosine phosphatase LAR: Proteolytic cleavage and shedding of the CAM-like extracellular region
33. The N-terminal and C-terminal domains of a receptor tyrosine phosphatase are associated by non-covalent linkage
34. Functional association between the insulin receptor and the transmembrane protein-tyrosine phosphatase LAR in intact cells
35. Suppression of insulin receptor activation by overexpression of the protein-tyrosine phosphatase LAR in hepatoma cells
36. Insulin receptor signaling is augmented by antisense inhibition of the protein tyrosine phosphatase LAR
37. The transmembrane protein-tyrosine phosphatase LAR modulates signaling by multiple receptor tyrosine kinases
38. Modulation of insulin signal transduction by eutopic overexpression of the receptor-type protein-tyrosine phosphatase LAR
39. Impaired mammary gland development and function in mice lacking LAR receptor-like tyrosine phosphatase activity
40. Capturing genes encoding membrane and secreted proteins important for mouse development
41. Deficient LAR expression decreases basal forebrain cholinergic neuronal size and hippocampal cholinergic innervation
42. Transgenic mice deficient in the LAR protein-tyrosine phosphatase exhibit profound defects in glucose homeostasis
43. A decrease in size and number of basal forebrain cholinergic neurons is paralleled by diminished hippocampal cholinergic innervation in mice lacking leukocyte common antigen-related protein tyrosine phosphatase activity
44. Overexpression of the LAR (leukocyte antigen-related) protein-tyrosine phosphatase in muscle causes insulin resistance
45. Tyrosine dephosphorylation and deactivation of insulin receptor substrate-1 by protein-tyrosine phosphatase 1B. Possible facilitation by the formation of a ternary complex with the Grb2 adaptor protein
46. Cloning and expression of a widely expressed receptor tyrosine phosphatase
47. Cell transformation and activation of pp60c-src by overexpression of a protein tyrosine phosphatase
48. Receptor protein tyrosine phosphatase alpha activates pp60c-src and is involved in neuronal differentiation
49. Identification of p130cas as an in vivo substrate of receptor protein- tyrosine phosphatase alpha
50. The transmembrane protein tyrosine phosphatase alpha dephosphorylates the insulin receptor in intact cells
51. Selective down-regulation of the insulin receptor signal by protein- tyrosine phosphatases alpha and epsilon
52. Overexpression of protein tyrosine phosphatase-alpha (PTP-alpha) but not PTP-kappa inhibits translocation of GLUT4 in rat adipose cells
53. Use of an antisense strategy to dissect the signaling role of protein-tyrosine phosphatase alpha
54. Targeted disruption of the tyrosine phosphatase PTPalpha leads to constitutive downregulation of the kinases Src and Fyn
55. Receptor protein tyrosine phosphatase alpha activates Src-family kinases and controls integrin-mediated responses in fibroblasts
56. Shp-2 tyrosine phosphatase: Signaling one cell or many
57. SH2-containing phosphotyrosine phosphatase as a target of protein- tyrosine kinases
58. Activation of a phosphotyrosine phosphatase by tyrosine phosphorylation
59. The insulin receptor substrate 1 associates with the SH2-containing phosphotyrosine phosphatase Syp
60. Activation of the SH2-containing phosphotyrosine phosphatase SH-PTP2 by its binding site, phosphotyrosine 1009, on the human platelet-derived growth factor receptor
61. Potent stimulation of SH-PTP2 phosphatase activity by simultaneous occupancy of both SH2 domains
62. Purification and characterization of PTP2C, a widely distributed protein tyrosine phosphatase containing two SH2 domains
63. 2-terminal mitogen-activated protein kinases
64. Dephosphorylation of insulin receptor substrate 1 by the tyrosine phosphatase PTP2C
65. Interaction of SH2-containing protein tyrosine phosphatase 2 with the insulin receptor and the insulin-like growth factor-I receptor: Studies of the domains involved using the yeast two-hybrid system
66. Adapter function of protein-tyrosine phosphatase 1D in insulin receptor/insulin receptor substrate-1 interaction
67. Identification by mutation of the tyrosine residues in the insulin receptor substrate-1 affecting association with the tyrosine phosphatase 2C and phosphatidylinositol 3-kinase
68. Identification of the major SHPTP2-binding protein that is tyrosine- phosphorylated in response to insulin
69. Syp (SHPTP2) is a positive mediator of growth factor-stimulated mitogenic signal transduction
70. Expression of catalytically inactive Syp phosphatase in 3T3 cells blocks stimulation of mitogen-activated protein kinase by insulin
71. Role of SH-PTP2, a protein-tyrosine phosphatase with Src homology 2 domains, in insulin-stimulated Ras activation
72. Protein-tyrosine-phosphatase SHPTP2 is a required positive effector for insulin downstream signaling
73. The COOH-terminal tyrosine phosphorylation sites on IRS-1 bind SHP-2 and negatively regulate insulin signaling
74. Association of insulin receptor substrate 3 with SH2 domain-containing proteins in rat adipocytes
75. Roles of the complex formation of SHPS-1 with SHP-2 in insulin-stimulated mitogen-activated protein kinase activation
76. Protein-tyrosine phosphatases PTP1B and syp are modulators of insulin- stimulated translocation of GLUT4 in transfected rat adipose cells
77. Abnormal mesoderm patterning in mouse embryos mutant for the SH2 tyrosine phosphatase Shp-2
78. Insulin signaling in mice expressing reduced levels of Syp
79. Expression of a dominant negative SHP-2 in transgenic mice induces insulin resistance
80. Characterization of the major protein-tyrosine-phosphatases of human placenta
81. The nontransmembrane tyrosine phosphatase PTP-1B localizes to the endoplasmic reticulum via its 35 amino acid C-terminal sequence
82. Human placenta protein-tyrosine-phosphatase: Amino acid sequence and relationship to a family of receptor-like proteins
83. Calpain-catalyzed cleavage and subcellular relocation of protein phosphotyrosine phosphatase 1B (PTP-1B) in human platelets
84. Molecular cloning and chromosome mapping of the human gene encoding protein phosphotyrosyl phosphatase 1B
85. Identification of an obesity quantitative trait locus on mouse chromosome 2 and evidence of linkage to body fat and insulin on the human homologous region 20q
86. Protein tyrosine phosphatase 1B interacts with the activated insulin receptor
87. Protein-tyrosine phosphatase 1B complexes with the insulin receptor in vivo and is tyrosine-phosphorylated in the presence of insulin
88. A synthetic tris-sulfotyrosyl dodecapeptide analogue of the insulin receptor 1146-kinase domain inhibits tyrosine dephosphorylation of the insulin receptor in situ
89. Down-regulation of insulin signaling by protein-tyrosine phosphatase 1B is mediated by an N-terminal binding region
90. Molecular basis for the dephosphorylation of the activation segment of the insulin receptor by protein tyrosine phosphatase 1B
91. Effect of microinjection of a low-Mr human placenta protein tyrosine phosphatase on induction of meiotic cell division in Xenopus oocytes
92. Microinjection of a protein-tyrosine-phosphatase inhibits insulin action in Xenopus oocytes
93. Osmotic loading of neutralizing antibodies demonstrates a role for protein-tyrosine phosphatase 1B in negative regulation of the insulin action pathway
94. Protein-tyrosine phosphatase 1B is a negative regulator of insulin-and insulin-like growth factor-I-stimulated signaling
95. Overexpression of protein tyrosine phosphatase 1B in adipocytes inhibits insulin-stimulated phosphoinositide 3 kinase activity without altering glucose transport or akt/pkb activation
96. Protein-tyrosine phosphatase-1B negatively regulates insulin signaling in l6 myocytes and Fao hepatoma cells
97. Insulin-stimulated hydrogen peroxide reversibly inhibits protein-tyrosine phosphatase 1b in vivo and enhances the early insulin action cascade
98. Insulin stimulates tyrosine phosphorylation and inactivation of protein tyrosine phosphatase 1B in vivo
99. Increased insulin sensitivity and obesity resistance in mice lacking the protein tyrosine phosphatase-1B gene
100. Increased energy expenditure, decreased adiposity, and tissue-specific insulin sensitivity in protein-tyrosine phosphatase 1B-deficient mice
101. Expression of protein-tyrosine phosphatases in the major insulin target tissues
102. Neuroendocrine dysplasia in mice lacking protein tyrosine phosphatase sigma
103. Neuronal defects and posterior pituitary hypoplasia in mice lacking the receptor tyrosine phosphatase PTPsigma
104. Comparative study of protein tyrosine phosphatase-epsilon isoforms: Membrane localization confers specificity in cellular signalling
105. Identification of tyrosine phosphatases that dephosphorylate the insulin receptor. A brute force approach based on substrate-trapping mutants
106. Decrease in beta-subunit phosphotyrosine correlates with internalization and activation of the endosomal insulin receptor kinase
107. Internalization and activation of the rat liver insulin receptor kinase in vivo
108. Endosomal proteolysis of insulin by an acidic thiol metalloprotease unrelated to insulin degrading enzyme
109. Selective degradation of insulin within rat liver endosomes
110. The dissociation and degradation of internalized insulin occur in the endosomes of rat hepatoma cells
111. Insulin receptor-associated protein tyrosine phosphatase(s): Role in insulin action
112. Inhibition of clathrin-mediated endocytosis selectively attenuates specific insulin receptor signal transduction pathways
113. Insulin receptor internalization and signalling
114. Tyrosine phosphorylation of the insulin receptor during insulin-stimulated internalization in rat hepatoma cells
115. Selective activation of the rat hepatic endosomal insulin receptor kinase. Role for the endosome in insulin signaling
116. The dephosphorylation of insulin and epidermal growth factor receptors. Role of endosome-associated phosphotyrosine phosphatase(s)
117. Dynamics of protein-tyrosine phosphatases in rat adipocytes
118. Dynamics of signaling during insulin-stimulated endocytosis of its receptor in adipocytes
119. Sub-cellular localization of insulin receptor substrate family proteins associated with phosphatidylinositol 3-kinase activity and alterations in lipolysis in primary mouse adipocytes from IRS-1 null mice
120. Compartmentalization and insulin-induced translocations of insulin receptor substrates, phosphatidylinositol 3-kinase, and protein kinase B in rat liver
121. Insulin signalling